Alphatec Holdings, Inc, a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced that Alphatec and Scient'x, S.A. have mutually terminated Alphatec's license from Scient'x of intellectual property related to the DYNAMO(tm) Semi Rigid Rod System. Terms of the termination include a repayment of the initial $2.6 million license fee originally paid to Scient'x and a full repayment of inventory that Alphatec will return to Scient'x.

According to Dirk Kuyper, President and Chief Executive Officer of Alphatec, DYNAMO did not fit within the new strategic direction of Alphatec and the repayment of $2.6 million will be used to support the commercialization of the company's innovative product development pipeline like the OsseoScrew, V-Stent, GLIF and other technologies targeted at the aging spine.

More Voices